Daily 1
99/100
This product looks safe
- Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 67% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Supplement Facts — Evidence Check
BioPQQ
5 mg
✅ Within RDA (0.7× RDA of 14 mg)
📚 193 studies (Tier A: 5, B: 63)
Vitamin A
1000 mcg
(125% DV)
Vitamin C
470 mg
(587% DV)
50 mcg
(1000% DV)
📊 3.3× RDA — above typical dose (UL: 0.1 mg)
📚 604 studies (Tier A: 16, B: 251)
80 mg
(665% DV)
📊 5.3× RDA — above typical dose (UL: 1000 mg)
📚 177 studies (Tier A: 3, B: 90)
75 mg
(6800% DV)
📊 62.5× RDA — above typical dose
📚 76 studies (Tier A: 0, B: 33)
50 mg
(3570% DV)
📊 38.5× RDA — above typical dose
📚 12 studies (Tier A: 0, B: 1)
50 mg
(310% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
50 mg
(830% DV)
📊 10.0× RDA — above typical dose
📚 1 studies — no high-quality reviews
12.5 mg
(890% DV)
📊 9.6× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
500 mcg
(250% DV)
✅ 1.2× RDA — within safe limits
📚 225 studies (Tier A: 10, B: 105)
400 mcg
(16000% DV)
📊 166.7× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
50 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
300 mcg
(600% DV)
📊 10.0× RDA — above typical dose
📚 26 studies (Tier A: 0, B: 11)
3 mg
📊 Market median: 3.0mg (58 products)
📚 2 studies — no high-quality reviews
200 mcg
(500% DV)
📊 5.7× RDA — above typical dose
📚 197 studies (Tier A: 1, B: 55)
150 mcg
(100% DV)
✅ Within RDA (1.0× RDA of 0.15 mg)
📚 243 studies (Tier A: 4, B: 133)
100 mg
(26% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
2 mg
(100% DV)
✅ Within RDA (0.9× RDA of 2.3 mg)
📚 8 studies — no high-quality reviews
100 mcg
(200% DV)
✅ 2.2× RDA — within safe limits
📚 2 studies — no high-quality reviews
150 mcg
(270% DV)
✅ 2.7× RDA — within safe limits
📚 172 studies (Tier A: 0, B: 67)
15 mg
(150% DV)
✅ 1.4× RDA — within safe limits
📚 258 studies (Tier A: 6, B: 134)
30 mg
📊 Market median: 200.0mg (198 products)
📚 6 studies — no high-quality reviews
15 mg
📊 Market median: 500.0mg (283 products)
📚 173 studies (Tier A: 0, B: 62)
11 mg
📊 Market median: 10.0mg (105 products)
📚 1 studies (Tier A: 0, B: 1)
10 mg
📊 Market median: 100.0mg (283 products)
📚 142 studies (Tier A: 1, B: 64)
Apigenin
5 mg
2 mg
📊 Market median: 4.0mg (47 products)
1 mg
📊 Market median: 10.0mg (35 products)
📚 5 studies (Tier A: 0, B: 2)
Other Ingredients
Calcium Carbonate
Stearic Acid
Maltodextrin
Croscarmellose Sodium
HPMC
Label Claims — Verification
❓
All Other
All Other (100% of products)
Structure/Function (90% of products)
Nutrient (28% of products)
Target Groups
Adult (18 - 50 Years)
Women (not pregnant or lactating)
Product Information
📋 Directions for Use
Take 1 tablet daily with a meal.
⚠️ Warnings & Precautions
Precautions: Contains iodine and a soy derivative.
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used to replace a varied, balanced diet or healthy lifestyle. As with any dietary supplement, consult a healthcare professional before consuming if you have a health condition.
Directions: For adults only. Keep out of young children's reach.
Not recommended for pregnant or breastfeeding women.
🧪 Formulation Notes
BioPQQ, Mitsubishi, Japan
Product Details
UPC / SKU
5 453003 828068
DSLD Entry Date
2025-09-25
Product Type
Other Combinations
Form
Tablet or Pill
Brand
SuperSmart
DSLD ID
339823
Data Updated
2026-04-11
Research Evidence
10
Research Sources
49
Avg Quality Score
8
Rct
1
Systematic Review
1
Clinical Trial
B
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
C
The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
C
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
C
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
C
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
C
Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
C
Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
C
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
C
A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.